Li Dean Y - Insider Non-Derivative Transactions at RECURSION PHARMACEUTICALS, INC. (RXRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 1, 2024, Li Dean Y's relationship to RECURSION PHARMACEUTICALS, INC. (RXRX) is Director, and currently has 73,778 shares of Class A Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RXRX insiders.
Data Source: SEC.
Li Dean Y - Insider Non-Derivative Transactions of RXRX Class A Common Stock
Li Dean Y - Insider Non-Derivative Transactions at RXRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 2, 2024 | Acquisition -- (Class A Common Stock) | 1592 | 0 | 73778 |
| Jun 4, 2024 | Acquisition -- (Class A Common Stock) | 13097 | 0 | 72186 |
| Apr 2, 2024 | Acquisition -- (Class A Common Stock) | 1267 | 0 | 59089 |
| Jan 10, 2024 | Sell -- (Class A Common Stock) | 962 | 14.03 | 421000 |
| Jan 10, 2024 | Sell -- (Class A Common Stock) | 28038 | 13.65 | 421962 |
| Jan 3, 2024 | Acquisition -- (Class A Common Stock) | 1203 | 0 | 1327618 |
| Oct 3, 2023 | Acquisition -- (Class A Common Stock) | 1659 | 0 | 1326415 |
| Jul 4, 2023 | Acquisition -- (Class A Common Stock) | 1609 | 0 | 637461 |
| Jun 17, 2023 | Acquisition -- (Class A Common Stock) | 12612 | 0 | 636021 |
| Apr 22, 2023 | G -- (Class A Common Stock) | 627705 | 0 | 0 |
| Apr 4, 2023 | Acquisition -- (Class A Common Stock) | 1724 | 0 | 623409 |
| Jan 4, 2023 | Acquisition -- (Class A Common Stock) | 1573 | 0 | 621685 |